Fenwick & West represented Relievant Medsystems, Inc., a medical device company pioneering the therapeutic use of nerve ablation within vertebral bodies for the treatment of chronic low back pain, in its $36 million equity financing. New Enterprise Associates led the financing which included participation from Canaan Partners, Emergent Medical Partners and Morgenthaler Ventures.
The company will use the funds to advance clinical development and commercial launch preparation for its novel INTRACEPT® therapy. More information about Relievant Medsystems’ $36 million equity financing can be obtained from the company press release.
The Fenwick transaction team was led by corporate lawyers Matt Rossiter, Ryan McRobert and Elizabeth Chang.